Doxorubicin and DNA minor groove-binding oligopeptide conjugates as anticancer agents.
Doxorubicin (Dor) and DNA minor groove-binding oligopeptide conjugates have been synthesized and their antitumor activities tested in vitro against KB cells. These new Dor analogues are less toxic to KB cells than the parent Dor.